◀ Back to PLA2G1B

NOX3 — PLA2G1B

Text-mined interactions from Literome

Chatterjee et al., J Biol Chem 2011 : We now demonstrate that Prdx6 is required for agonist induced NOX2 activation in pulmonary microvascular endothelial cells ( PMVEC ) and that the effect requires the PLA(2) activity of Prdx6
Björnsdottir et al., Exp Cell Res 2013 : Two of the seven inhibitors were without effect, two inhibitors inhibited both intra- and extracellular ROS production equally, and three inhibitors inhibited intracellular but not extracellular CL. Using another technique to measure ROS, PHPA oxidation, we found that intracellular ROS production was unaltered with the three last inhibitors, indicating that PLA(2) is not involved in the NADPH-oxidase activity per se, but in the intracellular processing of the radicals necessary for the CL reaction to take place
Krishnaiah et al., FASEB J 2013 : The phospholipase A2 (PLA2)activity of phosphorylated peroxiredoxin 6 (Prdx6) is required for activation of NADPH oxidase ( NOX2 )
Dana et al., Biochem J 1994 : Phospholipase A2 (PLA2) inhibitors suppressed simultaneously, in a dose dependent manner, the activation of NADPH oxidase and the release of 3H-labelled arachidonic acid ( [ 3H ] AA ) stimulated by either phorbol 12-myristate 13-acetate ( PMA ) or opsonized zymosan ( OZ ) in human neutrophils
Aviram et al., Isr J Med Sci 1996 (Arteriosclerosis) : Phospholipase A2 and phospholipase D are involved in macrophage NADPH oxidase mediated oxidation of low density lipoprotein
Lindsay et al., Perit Dial Int 1997 : These results imply that PDE induced NADPH-oxidase activation and priming in human neutrophils is mediated via a PLA2 dependent but PLC- and PLD independent mechanism